Middle East Escalation, a Cancer Breakthrough, and AI Eating Hollywood

In this episode of The Morning Rundown, hosts Maya and David cover a fast-moving week across geopolitics, medicine, and technology. From escalating conflict in the Middle East to a landmark cancer drug trial and a wave of AI-driven shifts in Hollywood and consumer tech, the episode breaks down complex, interconnected stories in plain language.Listeners will come away with a clearer picture of how the Iran nuclear negotiations, Israeli military operations in Lebanon, and U.S. military strikes are all pulling on the same thread, why a new daily pill called daraxonrasib represents a genuine turning point in pancreatic cancer treatment, and what it means that YouTubers are now outperforming major studios at the box office.Israel seizes Beaufort Castle in Lebanon, with Prime Minister Netanyahu framing the move as a decisive shift against Hezbollah, while U.S. and Iranian forces exchange direct military strikes and ceasefire negotiations stall.Daraxonrasib, a new oral drug for pancreatic cancer, nearly doubles survival time in clinical trial results just released, offering one of the most promising developments in years for one of the hardest-to-treat cancers.Ebola cases in the Democratic Republic of Congo reach 282, but the first five confirmed recoveries have been reported, providing cautious early hope as health officials monitor suspected cases outside Africa.The Backrooms earns $82 million on a $10 million budget, signaling that audiences, particularly younger viewers, will turn out for original concepts when they connect, not just franchise sequels.NVIDIA and Microsoft are shifting AI from the cloud to personal devices, with NVIDIA's RTX Spark superchip enabling on-device AI agents that run locally on Windows PCs.Subscribe and tune in each morning for clear, context-driven coverage of the stories shaping the day.